<code id='57C4792D7B'></code><style id='57C4792D7B'></style>
    • <acronym id='57C4792D7B'></acronym>
      <center id='57C4792D7B'><center id='57C4792D7B'><tfoot id='57C4792D7B'></tfoot></center><abbr id='57C4792D7B'><dir id='57C4792D7B'><tfoot id='57C4792D7B'></tfoot><noframes id='57C4792D7B'>

    • <optgroup id='57C4792D7B'><strike id='57C4792D7B'><sup id='57C4792D7B'></sup></strike><code id='57C4792D7B'></code></optgroup>
        1. <b id='57C4792D7B'><label id='57C4792D7B'><select id='57C4792D7B'><dt id='57C4792D7B'><span id='57C4792D7B'></span></dt></select></label></b><u id='57C4792D7B'></u>
          <i id='57C4792D7B'><strike id='57C4792D7B'><tt id='57C4792D7B'><pre id='57C4792D7B'></pre></tt></strike></i>

          explore

          explore

          author:entertainment    Page View:771
          Illustration: Alex Hogan/STAT; Photo: Courtesy Perrigo

          It’s not every day that a marketing team is tasked with designing the branding and packaging of the first over-the-counter birth control pill to be sold in the U.S.

          This was the challenge, and the opportunity, faced by the team behind Opill, the landmark pill from drugmaker Perrigo that received approval from the Food and Drug Administration earlier this month. Their brief: Create a design that would stand out in America’s notoriously sprawling pharmacy aisles; inspire trust and confidence; be easy to remember and recognize; appeal to women — including teenagers — as well as trans men and nonbinary people; clearly communicate its purpose; be simple to carry and use; contain straightforward but accurate user information; and clear FDA requirements.

          advertisement

          Settling on the right approach took years of research and testing, which resulted in the name Opill and packaging featuring bright teal, saturated pink, and yellow, as well as a rounded font reminiscent of millennials’ ubiquitous favorite Gotham. All of these features are intended to set the product apart from the dozens of prescription contraceptive pills available in the U.S. market and internationally.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Why ADHD is under
          Why ADHD is under

          At23,afternavigatingschoolandcollegeinanearlyperpetualstateofpanic,EmilyChenwasdiagnosedwithADHD.Van

          read more
          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more

          Weight loss drugs aren’t covered by Obamacare. That may change

          RHONAWISE/AFPviaGettyImagesWASHINGTON—Drugmakersaredoingeverythingtotapthebottomlesswellofdemandforn